Xenon Pharmaceuticals Inc. Uncategorized Contracts & Agreements
15 Contracts & Agreements
- Consent to Alterations Agreement between Redstone Enterprises Ltd. and Xenon Pharmaceuticals Inc., effective August 16, 2023 (Filed With SEC on February 29, 2024)
- Description of Securities (Filed With SEC on February 29, 2024)
- Consent to Alterations Agreement between Redstone Enterprises Ltd. and Xenon Pharmaceuticals Inc., effective March 27, 2023 (Filed With SEC on August 9, 2023)
- Description of Securities (Filed With SEC on March 9, 2020)
- Milestone and Royalty Buy-Out Agreement, dated September 7, 2018, by and among Xenon Pharmaceuticals Inc., Valeant Pharmaceuticals Ireland Limited and Valeant Pharmaceuticals... (Filed With SEC on September 11, 2018)
- Appendix A Xenon Pharmaceuticals Inc., & Genentech, Inc., Research Plan November 9, 2015 (Filed With SEC on March 8, 2016)
- ScheduleA-1 NaV1.6 (Filed With SEC on August 13, 2015)
- SCHEDULE A Disclosure of Volunteer, Board and Other External Commitments (Filed With SEC on October 6, 2014)
- SCHEDULE A Disclosure of Volunteer, Board and Other External Commitments (Filed With SEC on October 6, 2014)
- SCHEDULE A Disclosure of Volunteer, Board and Other External Commitments (Filed With SEC on October 6, 2014)
- SCHEDULE A Disclosure of Volunteer, Board and Other External Commitments (Filed With SEC on October 6, 2014)
- SCHEDULE A Disclosure of Volunteer, Board and Other External Commitments (Filed With SEC on October 6, 2014)
- SUBLICENSE AND RESEARCH AGREEMENT (Filed With SEC on October 6, 2014)
- EXCLUSIVE COLLABORATIVE RESEARCH AND OPTION AGREEMENT by and between MERCKSHARP & DOHME RESEARCH LTD. and XENON PHARMACEUTICALS INC. (Filed With SEC on October 6, 2014)
- TABLE OF CONTENTS (Filed With SEC on September 10, 2014)
